{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:05Z","timestamp":1759104185434,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancergeneticsjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.cancergencyto.2010.06.001","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T06:58:16Z","timestamp":1283237896000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel BRCA1\/2 mutations in Serbian breast and breast\u2013ovarian cancer patients with hereditary predisposition"],"prefix":"10.1016","volume":"202","author":[{"given":"Jelena","family":"Dobri\u010di\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjana","family":"Brankovi\u0107-Magi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sla\u0111ana","family":"Filipovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sini\u0161a","family":"Radulovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.06.001_bib1","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/sj.onc.1209874","article-title":"The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability","volume":"25","author":"Gudmundsdottir","year":"2006","journal-title":"Oncogene"},{"issue":"Suppl 6","key":"10.1016\/j.cancergencyto.2010.06.001_bib2","article-title":"Founder mutations in BRCA1 and BRCA2 genes","volume":"18","author":"Ferla","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ijc.20162","article-title":"A high proportion of founder BRCA1 mutations in Polish breast cancer families","volume":"110","author":"G\u00f3rski","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng1096-188","article-title":"The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%","volume":"14","author":"Oddoux","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng1294-392","article-title":"Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families","volume":"8","author":"Simard","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","article-title":"A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes","volume":"13","author":"Thorlacius","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/jnci\/djm207","article-title":"Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer","volume":"99","author":"Hosey","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2478","article-title":"Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features","volume":"12","author":"Tung","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004390100505","article-title":"Nomenclature for the description of human sequence variations","volume":"109","author":"den Dunnen","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib13","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1074\/jbc.274.9.5659","article-title":"Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1","volume":"274","author":"Meza","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrm2831","article-title":"BRCA1 and its toolbox for the maintenance of genome integrity","volume":"11","author":"Huen","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib15","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1073\/pnas.96.9.4983","article-title":"BRCA1 interacts with components of the histone deacetylase complex","volume":"96","author":"Yarden","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm.2000","article-title":"Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers","volume":"15","author":"Lim","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib17","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng0396-333","article-title":"The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds","volume":"12","author":"Tavtigian","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib19","doi-asserted-by":"crossref","first-page":"32931","DOI":"10.1074\/jbc.274.46.32931","article-title":"Expression of BRC repeats in breast cancer cells disrupts the BRCA2\u2013Rad51 complex and leads to radiation hypersensitivity and loss of G2\/M checkpoint control","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib20","doi-asserted-by":"crossref","first-page":"31941","DOI":"10.1074\/jbc.272.51.31941","article-title":"RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature01230","article-title":"Insights into DNA recombination from the structure of a RAD51\u2013BRCA2 complex","volume":"420","author":"Pellegrini","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/35044000","article-title":"In search of the tumour-suppressor functions of BRCA1 and BRCA2","volume":"408","author":"Scully","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2010.06.001_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810002360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810002360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:49:44Z","timestamp":1759045784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810002360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0165460810002360"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.06.001","relation":{},"ISSN":["0165-4608"],"issn-type":[{"type":"print","value":"0165-4608"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel BRCA1\/2 mutations in Serbian breast and breast\u2013ovarian cancer patients with hereditary predisposition","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics and Cytogenetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}